Research IPOs and Discover New Stocks
BioVentrix, a medical device firm developing minimally invasive treatments for heart failure, withdrew its plans for an initial public offering on Wednesday. It originally filed in February 2026 with a proposed deal size of $17 million, but never set terms. It...read more
Frazier Life Sciences Acquisition II, the second blank check company formed by Frazier targeting biotech, raised $75 million by offering 7.5 million shares at $10. Unlike most SPACs, it did not offer units with warrants or rights attached. Frazier Life...read more
Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses why investors said no to Firmus' Australian IPO. To stay on top of the IPO market, make sure to sign up for our weekly newsletter.
...read more
Track the top IPOs from the past 3 years by market cap.
| Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|
| Frazier Life Sciences II | FLSC | Get date on IPO Pro | 7.5 | $10.00 - $10.00 | $75 | Jefferies |
| City Therapeutics | CTY | Get date on IPO Pro | 9.7 | $17.00 - $19.00 | $175 | Goldman Jefferies |
| Iambic Therapeutics | IAM | Get date on IPO Pro | 9.4 | $15.00 - $17.00 | $150 | JP Morgan Jefferies |
| Harbour Island Acq. I | HRIAU | Get date on IPO Pro | 10.0 | $10.00 - $10.00 | $100 | Clear Street |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals | RTSN | 10/08/26 | $45 | $11.44 |
$-0.19
(-1.6%)
|
-4.7% |
| TRex Bio | TRXB | 10/08/26 | $117 | $13.48 |
$-0.12
(-0.9%)
|
-3.7% |
| Accelevation | ACCV | 09/29/26 | $540 | $14.23 |
$-1.08
(-7.1%)
|
-20.9% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Preview
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
